A detailed history of Central Pacific Bank Trust Division transactions in Pfizer Inc stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 18,118 shares of PFE stock, worth $479,039. This represents 0.06% of its overall portfolio holdings.

Number of Shares
18,118
Previous 9,286 95.11%
Holding current value
$479,039
Previous $269 Million 78.86%
% of portfolio
0.06%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 03, 2025

BUY
$24.8 - $30.19 $219,033 - $266,638
8,832 Added 95.11%
18,118 $481 Million
Q3 2024

Oct 02, 2024

BUY
$27.7 - $31.39 $107,476 - $121,793
3,880 Added 71.77%
9,286 $269 Million
Q2 2024

Jul 30, 2024

BUY
$25.26 - $29.6 $12,630 - $14,800
500 Added 10.19%
5,406 $151 Million
Q1 2024

May 02, 2024

BUY
$25.89 - $29.73 $127,016 - $145,855
4,906 New
4,906 $136 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.